孕期心理描述：：Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 4 Statement of changes in beneficial ownership of securities Accession Number: 0000947871-22-001263  Size: 7 KB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001558370-22-019036  Act: 34  Size: 9 MB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 8-K Current report, item 5.02 Accession Number: 0001104659-22-121812  Act: 34  Size: 196 KB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-22-129703  Act: 33  Size: 603 KB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0000947871-22-001262  Act: 34  Size: 65 KB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-22-130714  Act: 34  Size: 276 KB 網頁鏈接 Outlook Therapeutics(OTLK)： Outlook Therapeutics(OTLK) 8-K Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01 Accession Number: 0001104659-22-129610  Act: 34  Size: 496 KB 網頁鏈接